Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-02 @ 7:13 AM
Study NCT ID:
NCT03657966
Status:
COMPLETED
Last Update Posted:
2021-04-21
First Post:
2018-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer
Sponsor:
SOTIO a.s.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ovarian Cancer Recurrent | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Immunotherapy | View |
| None | Platinum-sensitive | View |
| None | Biologic | View |
| None | Vaccine | View |
| None | Ovarian cancer | View |
| None | Fallopian Tube cancer | View |
| None | Primary peritoneal cancer | View |
| None | dendritic cells | View |
| None | chemotherapy | View |
| None | leukapheresis | View |
| None | FIGO III | View |
| None | FIGO IV | View |